Algiax raises €2.2M Seed round
3 November 2011· Erkrath, Germany· health, pharmaceuticals, biotech, b2b, deep_hardware, drug_discovery
The investment will be used for the development of novel therapies for neuropathic pain and to bring the lead candidate through preclinical development.
Investors
LeadHigh-Tech Gründerfonds
Also participating
NRW.Bank
About Algiax
Stage
Series B
Headquarters
Erkrath, Germany
Founded
2011
Team Size
6–20
Sectors
healthpharmaceuticalsbiotechb2bdeep_hardwaredrug_discovery